Visit Novo Nordisk Pharmatech, booth 5B1 at CPHI Worldwide
An innovative synthesis process makes Novo Nordisk Pharmatech a leading supplier of crystalline Quats for a wide range of applications. High levels of purity for products such as benzalkonium chloride, cetrimide, cetrimonium bromide (CTAB) and a range of others make them particularly suited for pharmaceutical applications, such as vaccine production. They act either as preservatives or active ingredients in many ophthalmic, nasal, oral and topical drugs and in a variety of solutions, ointments and creams.
Novo Nordisk Pharmatech experts can advise customers about the right product for their formulation, or develop a custom-designed product to meet specific needs.
The company adheres to the latest European guidelines on Good Distribution Practice (GDP), and all Quats are manufactured in accordance with the cGMP Guide ICH Q7 for Active Pharmaceutical Ingredients, the highest available standard. Quality analyses are done according to multicompendial pharmacopoeias (BP, Ph.Eur., USP/NF and JP) and are part of the regulatory documentation ensuring global compliance.
Our FeF Benzalkonium Chloride, FeF Cetrimide Ph.Eur., FeF CTAB USP/NF and Strong Cetrimide Solution 40% BP Pharma can be differentiated for example by their form (powder, viscous liquid, solution), by the alkyl (carbon) chain length of the tertiary amines used, and by their anion (chloride or bromide).
For more information visit our booth 5B1 at CPHI Worldwide or our website: www.novonordiskpharmatech.com